Commodore Capital LP Dyne Therapeutics, Inc. Transaction History

Commodore Capital LP

  • $1.18 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$6.62 - $13.64 $5.96 Million - $12.3 Million
900,000 New
900,000 $12 Million
Q2 2022

Aug 15, 2022
SELL
$4.36 - $10.5 $1.33 Million - $3.2 Million
-305,125 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$15.94 - $22.33 $1.99 Million - $2.79 Million
-124,987 Reduced 29.06%
305,125 $6.42 Million
Q1 2021

May 17, 2021
BUY
$14.0 - $29.3 $6.02 Million - $12.6 Million
430,112 New
430,112 $6.68 Million

Others Institutions Holding DYN

# of Institutions
210
Shares Held
102M
Call Options Held
234K
Put Options Held
238K
View Full List

About Dyne Therapeutics, Inc.

DYN Quotes by TradingView
  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.54B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Commodore Capital LP Portfolio

Follow Commodore Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commodore Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Commodore Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email